1
|
Kirsch M, Dimitrijevic A, Buchholz MB. “Death drive” scientifically reconsidered: Not a drive but a collection of trauma-induced auto-addictive diseases. Front Psychol 2022; 13:941328. [PMID: 36248574 PMCID: PMC9554588 DOI: 10.3389/fpsyg.2022.941328] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Download PDF] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/11/2022] [Accepted: 09/06/2022] [Indexed: 11/13/2022] Open
Abstract
Over the last 102 years, a lot of discussion was being held about the psychoanalytic conception of the “death drive,” but still with inconclusive results. In this paper, we start with a brief review of Freud’s conception, followed by a comprised overview of its subsequent support or criticisms. The core of our argument is a systematic review of current biochemical research about two proposed manifestations of the “death drive,” which could hopefully move the discussion to the realm of science. It was already established that drive satisfaction leads to the secretion of beta-endorphins, and research evidence also shows that the same biochemical mechanisms get activated in the case of masochism and the gambling disorder but only if they are preceded by chronic frustration of the essential drives. We conclude that the actual situation is more complex than Freud hypothesized, and that a fundamental revision of the psychoanalytic drive theory is necessary.
Collapse
Affiliation(s)
- Michael Kirsch
- Institute of Physiological Chemistry, University Hospital Essen, Essen, Germany
- *Correspondence: Michael Kirsch,
| | | | | |
Collapse
|
2
|
Johnson B, Brand D, Zimmerman E, Kirsch M. Drive, instinct, reflex—Applications to treatment of anxiety, depressive and addictive disorders. Front Psychol 2022; 13:870415. [PMID: 36225690 PMCID: PMC9549915 DOI: 10.3389/fpsyg.2022.870415] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/14/2022] [Accepted: 07/28/2022] [Indexed: 11/13/2022] Open
Abstract
The neuropsychoanalytic approach solves important aspects of how to use our understanding of the brain to treat patients. We describe the neurobiology underlying motivation for healthy behaviors and psychopathology. We have updated Freud’s original concepts of drive and instinct using neuropsychoanalysis in a way that conserves his insights while adding information that is of use in clinical treatment. Drive (Trieb) is a pressure to act on an internal stimulus. It has a motivational energic source, an aim, an object, and is terminated by the satisfaction of a surge of serotonin. An instinct (Instinkt) is an inherited pattern of behavior that varies little from species to species. Drives are created by internal/ventral brain factors. Instincts require input from the outside that arrive through dorsal brain structures. In our model unpleasure is the experience of unsatisfied drives while pleasure if fueled by a propitious human environment. Motivational concepts can be used guide clinical work. Sometimes what had previously described psychoanalytically as, “Internal conflict,” can be characterized neurobiologically as conflicts between different motivational systems. These motivational systems inform treatment of anxiety and depression, addiction in general and specific problems of opioid use disorder. Our description of motivation in addictive illness shows that the term, “reward system,” is incorrect, eliminating a source of stigmatizing addiction by suggesting that it is hedonistic. Understanding that motivational systems that have both psychological and brain correlates can be a basis for treating various disorders. Over many papers the authors have described the biology of drives, instincts, unpleasure and pleasure. We will start with a summary of our work, then show its clinical application.
Collapse
Affiliation(s)
- Brian Johnson
- Department of Psychiatry, State University of New York, Upstate Medical University, Syracuse, NY, United States
- *Correspondence: Brian Johnson,
| | - David Brand
- Department of Psychology, Adelphi University, Garden City, NY, United States
| | - Edward Zimmerman
- Department of Psychiatry, State University of New York, Upstate Medical University, Syracuse, NY, United States
| | - Michael Kirsch
- Institute of Physiological Chemistry, University Hospital Essen, Essen, Germany
| |
Collapse
|